Listen Score
LS 38
Global Rank
TOP 2%

INFORMAZIONI SU QUESTO PODCAST 🔗

Conduttori:
Frequenza di aggiornamento:
every 16 days
Durata media dell'audio:
16 minutes
Inglese
Stati Uniti
144 episodi
da 30 Settembre 2019
episodic

CERCA TRA GLI EPISODI PASSATI

Cerca gli episodi passati di Primary Care Pod.

EPISODI PRECEDENTI

Fun, quick episode this week.    https://pubmed.ncbi.nlm.nih.gov/33934725/   Non-fatal senior pickleball and tennis-related injuries treated in United States emergency departments, 2010-2019   Harold Weiss 1, Jacob Dougherty 2, Charles DiMaggio 3
Today's episode is a very complicated topic without clear cut benefits. Expert opinions and modeling data to address a dangerous and serious topic. Let's look at 2 sources: a new study from the Annals of Internal Medicine and an expert opinion from Uptodate.   https://www.uptodate.com/contents/se…
Time restricted eating vs. caloric restriction. Is there a winner in this 1:1:1 12-month trial from Chicago?   https://pubmed.ncbi.nlm.nih.gov/37364268/ Time-Restricted Eating Without Calorie Counting for Weight Loss in a Racially Diverse Population : A Randomized Controlled Trial Shuhao Lin 1,…
Talking about 2 studies released last month:   1. Giving it to 3rd trimester moms and seeing what happens in newborns: https://pubmed.ncbi.nlm.nih.gov/37018474/   2. Giving it to 60+ yo adults and seeing what happens: https://pubmed.ncbi.nlm.nih.gov/37018468/   What happens when I review th…
Hey everyone, on today's episode we are talking about a recent JAMA article on Heterogeneity in Blood Pressure Response to various blood pressure medicines and the idea of individualizing antihypertensive algorithms.   https://jamanetwork.com/journals/jama/article-abstract/2803518
Today's episode we look at a study of 60+ year olds who have poorly controlled depression.  Is it better to add on medications? Switch medications? Does it matter?    Study link: https://pubmed.ncbi.nlm.nih.gov/36867173/
Bempedoic Acid aka Nexletol has a new trial in NEJM that shows MACE reduction in very high risk patients (mostly secondary but some primary prevention).  NNT? NNH? Other trials on Bempedoic acid? Tune in and find out.    
Interesting study today that looks at High dose ICS inhalers possibly have worse outcomes in patients than medium dose ICS inhalers, leading to more exacerbations and need for antibiotics. Plausible? Let's discuss!
We take a Pre-operative study from the Annals of Surgery and talk about perioperative risk management for patients with low serum creatinine.
Dichiarazione di non responsabilità: Il podcast e la grafica incorporati in questa pagina provengono da Dr. Mark List, che è di proprietà del suo proprietario e non è affiliato o approvato da Listen Notes, Inc.